Training Program in Hematology and Oncology in the Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University School of Medicine

Program Goals and Objectives :: The major goal of our program is to educate and train the Hematology and Oncology academic thought leaders and investigators of tomorrow.

The Hematology and Oncology Fellowship has high expectations for self-directed learning, and seeks to train physician specialists who are prepared to expertly treat disease using an evidence-based approach and patient-centered care, and who appreciate the social and behavioral context of illness. We emphasize opportunities for clinical and basic research for all of our fellows. Our curriculum and clinical teaching and training interweave themes of basic science, medical knowledge, research and scholarship, clinical mastery, leadership, and civic professionalism.

Program Description :: The hematology and medical oncology fellowship is an ACGME accredited program.  Two and 3-year training programs in hematology and/or medical oncology are available, leading to eligibility to sit for the Hematology and/or Medical Oncology ABIM board examinations. Emphasis in the first year is on clinical training in both medical oncology and hematology. In the second and third years, research career development is emphasized. A single board certification requires 12 months of clinical training in a 24 month period; dual board certification requires 18 months clinical training in 36 months. Throughout the 2-3 year program, a continuous outpatient continuity clinic is maintained one ½ day a week. Additional clinics can be added based upon the trainee’s clinical and subspecialty research interest in years two and three.

The Fellowship Training Program is an integrated program between 3 hospitals:

  • University Hospital Case Medical Center
  • The Louis Stokes Cleveland Veteran's Affairs Medical Center
  • MetroHealth Medical Center

Clinical outpatient rotations occur at each institution. Inpatient rotations include hematology and oncology consultation, hematology and oncology service management, and stem cell and hematologic malignancy service.